Literature DB >> 22948876

In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.

Peiying Feng1, M Javad Najafzadeh, Jiufeng Sun, Sarah Ahmed, Liyan Xi, G Sybren de Hoog, Wei Lai, Chun Lu, Corné H Klaassen, Jacques F Meis.   

Abstract

Cyphellophora guyanensis (n = 15), other Cyphellophora species (n = 11), Phialophora europaea (n = 43), and other Phialophora species (n = 12) were tested in vitro against nine antifungal drugs. The MIC(90)s across all of the strains (n = 81) were, in increasing order, as follows: posaconazole, 0.063 μg/ml; itraconazole, 0.5 μg/ml; voriconazole, 1 μg/ml; micafungin, 1 μg/ml; terbinafine, 2 μg/ml; isavuconazole, 4 μg/ml; caspofungin, 4 μg/ml; fluconazole, 8 μg/ml; amphotericin B, 16 μg/ml.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22948876      PMCID： PMC3486609          DOI： 10.1128/AAC.01112-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  A new species, Phialophora europaea, causing superficial infections in humans.

Authors:  G S de Hoog; P Mayser; G Haase; R Horré; A M Horrevorts
Journal:  Mycoses       Date:  2000       Impact factor: 4.377

Review 2.  Isavuconazole: a comprehensive review of spectrum of activity of a new triazole.

Authors:  George R Thompson; Nathan P Wiederhold
Journal:  Mycopathologia       Date:  2010-06-05       Impact factor: 2.574

3.  Growth characteristics of four fungal species in bathrooms.

Authors:  Nobuo Hamada; Niichiro Abe
Journal:  Biocontrol Sci       Date:  2010-09       Impact factor: 0.982

Review 4.  The new fungal opportunists are coming.

Authors:  J R Perfect; W A Schell
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

5.  In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan.

Authors:  Toshikazu Yamazaki; Yukiko Inagaki; Toshihiko Fujii; Jun Ohwada; Masao Tsukazaki; Isao Umeda; Kazuko Kobayashi; Nobuo Shimma; Malcolm G P Page; Mikio Arisawa
Journal:  Int J Antimicrob Agents       Date:  2010-07-31       Impact factor: 5.283

6.  Black yeast-like fungi in skin and nail: it probably matters.

Authors:  D M Saunte; B Tarazooie; M C Arendrup; G S de Hoog
Journal:  Mycoses       Date:  2011-07-08       Impact factor: 4.377

7.  Description of Cyphellophora pluriseptata sp. nov.

Authors:  G A De Vries; M C Elders; M H Luykx
Journal:  Antonie Van Leeuwenhoek       Date:  1986       Impact factor: 2.271

Review 8.  Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections.

Authors:  Jesús Guinea; Emilio Bouza
Journal:  Future Microbiol       Date:  2008-12       Impact factor: 3.165

9.  In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.

Authors:  Mohammad J Najafzadeh; Hamid Badali; Maria Teresa Illnait-Zaragozi; G Sybren De Hoog; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

10.  Waterborne Exophiala species causing disease in cold-blooded animals.

Authors:  G S de Hoog; V A Vicente; M J Najafzadeh; M J Harrak; H Badali; S Seyedmousavi
Journal:  Persoonia       Date:  2011-11-16       Impact factor: 11.051
View more
  10 in total

1.  Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.

Authors:  Yongxuan Hu; Xiaowen Huang; Sha Lu; Michael R Hamblin; Eleftherios Mylonakis; Junmin Zhang; Liyan Xi
Journal:  Mycopathologia       Date:  2014-11-01       Impact factor: 2.574

2.  In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.

Authors:  M J Najafzadeh; M Saradeghi Keisari; V A Vicente; P Feng; S A A Shamsian; A Rezaei-Matehkolaei; G S de Hoog; I Curfs-Breuker; J F Meis
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

3.  In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.

Authors:  S Deng; G S de Hoog; H Badali; L Yang; M J Najafzadeh; B Pan; I Curfs-Breuker; J F Meis; W Liao
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

4.  Reflections on the approach to treatment of a mycologic disaster.

Authors:  David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2013-02-05       Impact factor: 5.191

5.  In vitro activities of nine antifungal drugs and their combinations against Phialophora verrucosa.

Authors:  Yali Li; Zhe Wan; Ruoyu Li
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

Review 6.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 7.  Phaeohyphomycoses, emerging opportunistic diseases in animals.

Authors:  S Seyedmousavi; J Guillot; G S de Hoog
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

8.  Indoor wet cells as a habitat for melanized fungi, opportunistic pathogens on humans and other vertebrates.

Authors:  Xiaofang Wang; Wenying Cai; A H G Gerrits van den Ende; Junmin Zhang; Ting Xie; Liyan Xi; Xiqing Li; Jiufeng Sun; Sybren de Hoog
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

9.  Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.

Authors:  Yongxuan Hu; Xinyu Qi; Hengbiao Sun; Yan Lu; Yanqing Hu; Xuyang Chen; Kangxing Liu; Yemei Yang; Zuhao Mao; Zhong Wu; Xianyi Zhou
Journal:  PLoS Negl Trop Dis       Date:  2019-10-31

10.  A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi Successfully Treated by Oral Itraconazole Together with Terbinafine.

Authors:  Xu-Cheng Shen; Xiang-Nong Dai; Zhi-Min Xie; Ping Li; Sha Lu; Jia-Hao Li; Yi Zhang; Xing-Dong Ye
Journal:  Dermatol Ther (Heidelb)       Date:  2020-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.